Trial intelligence / Profile preview

Yunnan Baiyao Capsules plus internal fixation for hip fracture healing

ChiCTR2500098150Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Yunnan Baiyao in hip fracture (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Degree of callus healing under X-ray and Harris hip score. Planned start Mar 2025; status: not yet recruiting.

02

Drugs

Yunnan Baiyao
03

Conditions

hip fracture

Beyond the preview

Go deeper on ChiCTR2500098150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500098150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call